4 Contradicted by research
Falling estrogen levels in women cause a reduction in gut microbial diversity.
"as estrogen levels start to fall and progesterone levels start to fall, but mostly estrogen, you start to see a reduction in microbial diversity within the gut microbiome. And this has been shown across the board with women." (said at 0:02:09)
A systematic review and meta-analysis comparing hypoestrogenic women (postmenopausal or with premature ovarian insufficiency, n=1,267) to euestrogenic premenopausal controls (n=463) found no significant difference in gut microbial alpha-diversity (Shannon index, p=0.990) or major bacterial phyla. While some individual observational studies have reported modest shifts in specific bacterial taxa or non-significant trends, there is no consistent evidence 'across the board' that falling estrogen levels cause a decrease in gut microbial diversity.
- contradicts: Age-Related Changes, Influencing Factors, and Crosstalk Between Vaginal and Gut Microbiota… (Journal of women's health (2002) 2022) · cited 28x in the literature
"The compositions of the vaginal microbiota were significantly different in pre- and postmenopausal women. However, such differences were not noticeable in the gut microbiota." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: The impact of estrogen status on the gut microbiome: a systematic review and meta-analysis… (Frontiers in endocrinology 2026) · cited 4x in the literature
"Out of 1092 studies screened, 7 met the inclusion criteria (n = 45 women with POI, n = 1222 post-menopausal women, n = 463 eustrogenic controls). No significant differences were observed in α-diversity (p=0.990), Bacteroidetes (p=0.440), or Firmicutes abundance (p=0.110) between hypoestrogenic and euestrogenic groups, irrespective of POI or postmenopause." (abstract, results)
pubmedfull study (doi)
Elevated lipopolysaccharide (LPS) can reduce testosterone production in women.
"LPS as LPS increases as that lipopolysaccharide increases, it actually can reduce testosterone production even in women" (said at 0:07:15)
The claim states that elevated lipopolysaccharide (LPS) reduces testosterone production in women, which inverts the observed biological relationship. While chronic endotoxemia suppresses testicular steroidogenesis and lowers testosterone in males, in females LPS exposure stimulates ovarian androgen production. In clinical studies, circulating LPS and endotoxemia markers correlate positively with testosterone levels and hyperandrogenic symptoms in women (such as in polycystic ovary syndrome).
In the 9-year Netherlands Study on Anxiety and Depression, serum LPS was the only biomarker associated with 100% of anxiety and depression cases and predicted symptom severity.
"there was a 9-year long study called the Netherlands Study on Anxiety and Depression, where they were looking at a number of biomarkers in people that were suffering from anxiety and depression, and then they followed them for 9 years to look at the best associated biomarkers with the condition. They found only one biomarker was associated with 100% of the cases of anxiety and depression, and the level of that biomarker could predict how severe their anxiety and depression was. And in fact, in that 9-year follow-up, for any individuals who that biomarker went away, anxiety and depression went away as well. And that one biomarker was LPS, with serum LPS levels." (said at 0:12:35)
The claim significantly mischaracterizes the methodology and findings of the Netherlands Study of Depression and Anxiety (NESDA). NESDA did not measure circulating serum LPS (endotoxin) levels as a biomarker. Instead, researchers used LPS in vitro as an ex vivo laboratory reagent to stimulate blood samples and assess immune cell cytokine production capacity (such as IL-6, IL-8, and TNF-alpha). Furthermore, no biomarker in NESDA was associated with 100% of anxiety or depression cases, nor did symptoms resolve in 100% of individuals whose inflammatory markers normalized. The actual published NESDA analyses demonstrated small effect sizes (such as standardized beta coefficients up to ~0.14) connecting basal and LPS-stimulated cytokine production capacity with anxiety and depressive symptom persistence over 9 years, much of which was attenuated after controlling for health and lifestyle factors.
- contradicts: Cytokine production capacity in depression and anxiety. (Translational psychiatry 2016) · cited 199x in the literature
"Few studies examined the expression of cytokines in response to ex vivo stimulation of blood by lipopolysaccharide (LPS) to study the innate production capacity of cytokines in depression and anxiety. To investigate this, baseline data from the Netherlands Study of Depression and Anxiety (NESDA) were used" (abstract, background, passage verified)
pubmedfull study (doi) - contradicts: Basal and LPS-stimulated inflammatory markers and the course of anxiety symptoms. (Brain, behavior, and immunity 2021) · cited 31x in the literature
"In conclusion, we found that participants with high levels of inflammatory markers have on average high levels of anxiety consisting of physical arousal and agoraphobia, which tended to persist over a period of nine years, albeit with small effect sizes." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Lipopolysaccharide (LPS) induces bone inflammation that promotes osteoclast-mediated bone resorption over osteoblast activity, driving osteoporosis.
"LPS also drives inflammation in the bone. Inflammation in the bone changes these uh cells called osteoclastic cells, which build bone into Sorry, osteoblastic cells, which build bone into osteoclastic cells, which actually reabsorb reabsorb bone and and uh makes makes bone weaker. Um so it drives osteoporosis as well, right?" (said at 0:14:34)
While lipopolysaccharide (LPS) and chronic inflammation promote bone resorption by stimulating osteoclast differentiation and suppressing osteoblast-mediated bone formation, osteoblasts do not transform into osteoclasts. Osteoblasts and osteoclasts arise from two completely distinct cell lineages: osteoblasts develop from mesenchymal stem cells (mesenchymal lineage), whereas osteoclasts differentiate from hematopoietic stem cells and monocyte/macrophage precursors (hematopoietic lineage). In LPS-induced inflammatory bone loss, LPS stimulates Toll-like receptor 4 (TLR4) on osteoblasts and immune cells to upregulate inflammatory mediators, prostaglandins, and receptor activator of nuclear factor-kappa B ligand (RANKL), which recruit and differentiate macrophage/monocyte precursors into active osteoclasts rather than transdifferentiating osteoblasts.
- context: Roles of Toll-like Receptor Signaling in Inflammatory Bone Resorption. (Biology 2024) · cited 38x in the literature
"The ligands for TLR2/1, TLR2/6, TLR3, and TLR5, as well as TLR4, induce osteoclast differentiation associated with the production of PGE2 and the receptor activator of nuclear factor-kappa B ligand (RANKL), an inevitable inducer of osteoclast differentiation in osteoblasts." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Early Growth Response 1 Plays an Essential Role in Proinflammatory and Osteoclastogenic Ac… (FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2025) · cited 3x in the literature
"LPS induces osteoblasts to express proinflammatory cytokines, chemokines, and prostaglandins, as well as macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL), which directly activate adjacent osteoclasts toward bone resorption." (abstract, results)
pubmedfull study (doi) - contradicts: Cibotii Rhizoma Extract Mitigates LPS-Induced Inflammatory Bone Loss by Inhibiting the RAN… (Advanced biology 2026)
"CR suppressed receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis in bone marrow-derived monocyte/macrophage (BMM) cultures by downregulating NFATc1, c-Src, and TRAF6, thereby inhibiting osteoclast formation, podosomal actin ring assembly, and cell fusion." (abstract, results, passage verified)
pubmedfull study (doi)
14 Overstated
Studies comparing premenopausal and perimenopausal women show circulating LPS levels are significantly higher in perimenopause.
"In fact, there are studies that look at women in premenopause versus women in perimenopause, and the the amount of circulating LPS is dramatically higher, right?" (said at 0:02:49)
While longitudinal research across the menopausal transition shows evidence of increased gut barrier permeability and microbial translocation, the claim that circulating lipopolysaccharide (LPS) is "dramatically higher" in perimenopausal compared to premenopausal women is overstated. In a longitudinal cohort from the Study of Women's Health Across the Nation (SWAN; n = 65), surrogate markers of microbial translocation and gut permeability increased modestly across the menopause transition (from pre- to postmenopause): LPS-binding protein (LBP) increased by 3.7% (P = 0.05), soluble CD14 (sCD14) by 8.9% (P = 0.0002), and fatty acid binding protein 2 (FABP2) by 22.8% (P = 0.001). Direct measurements of circulating LPS do not show dramatic spikes between premenopause and perimenopause.
- partial: Gut permeability, inflammation, and bone density across the menopause transition. (JCI insight 2020) · cited 93x in the literature
"In our primary analysis, FABP2, LBP, and sCD14 increased by 22.8% (P = 0.001), 3.7% (P = 0.05), and 8.9% (P = 0.0002), respectively, from pre- to postmenopause." (abstract, results, passage verified)
pubmedfull study (doi)
A reduction in gut Lactobacilli and Bifidobacteria species is associated with increased weight and a reduction in basal metabolic rate.
"We also tend to see a reduction in lactobacilli uh and bifidobacteria species as well, which both of those reductions then have a weight effect as well because uh reduction in lacto and bifido is associated with an increase in weight and a and a reduction of basal metabolic rate in people." (said at 0:04:30)
While lower relative abundances of Bifidobacterium species (and certain Lactobacillus species) are frequently observed in individuals with obesity compared to lean individuals, and their metabolites (such as short-chain fatty acids) are involved in host metabolic regulation and thermogenesis in preclinical models, the assertion that a reduction in these bacteria is directly associated with or causes a reduction in basal metabolic rate in humans is overstated. Clinical research directly evaluating resting energy expenditure in relation to gut microbiota composition remains very limited and preliminary, with only recent small trials beginning to explore whether specific probiotic strains can influence resting energy expenditure.
- partial: Effect of Intake of Bifidobacteria and Dietary Fiber on Resting Energy Expenditure: A Rand… (Nutrients 2024) · cited 10x in the literature
"At week 4, the REE score of the GCL2505 and inulin group was significantly higher than that of the placebo group, with a difference of 84.4 kcal/day. In addition, fecal bifidobacteria counts were significantly increased in the GCL2505 and inulin group. Our results indicated that the intake of GCL2505 and inulin improves energy balance, which is known to be a major factor of obesity, by modulating the microbiota in the gut. This is the first report to demonstrate the effects of probiotics and dietary fiber on REE in humans." (abstract, results, passage verified)
pubmedfull study (doi) - context: Unraveling the gut microbiota's role in obesity: key metabolites, microbial species, and t… (Journal of bacteriology 2025) · cited 45x in the literature
"Conversely, beneficial bacteria like Akkermansia muciniphila , Lactobacillus spp., and Bifidobacterium spp. enhance gut barrier integrity, regulate SCFA production, and modulate fasting-induced adipose factor, which collectively support metabolic health by reducing fat storage and inflammation. Metabolites such as SCFAs (acetate, propionate, and butyrate) interact with G-protein coupled receptors to regulate lipid metabolism and promote the browning of white adipose tissue (WAT), thus enhancing thermogenesis and energy expenditure." (abstract, passage verified)
pubmedfull study (doi)
Women entering perimenopause experience a significant increase in systemic inflammatory markers including hs-CRP, IL-6, and TNF-alpha.
"so, when you look at systemic inflammation in women entering perimenopause, you see a significant rise in things like hs-CRP, which is a global inflammatory marker, interleukin-6, TNF-alpha." (said at 0:04:50)
While longitudinal cohort studies observe elevations in certain inflammatory markers across the menopausal transition, asserting a uniform, significant rise across hs-CRP, IL-6, and TNF-alpha upon entering perimenopause overstates the findings. In the longitudinal Penn Ovarian Aging Study (PMID: 34589780), log IL-6 levels were significantly higher in late perimenopause compared to premenopause, but increases were nuanced, showed significant interactions with early life adversity, and did not demonstrate a uniform baseline rise across hs-CRP and TNF-alpha. Furthermore, prospective studies examining the menopausal transition (such as PMID: 19126626) demonstrate that changes in systemic inflammatory markers like CRP are strongly mediated by concomitant increases in visceral adiposity rather than being an isolated universal cytokine surge across all these markers.
- context: Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prosp… (The Journal of clinical endocrinology and metabolism 2009) · cited 278x in the literature
"The increase in intraabdominal fat was correlated positively with the change in SAA (r = 0.31, P = 0.02), CRP (r = 0.56, P < 0.001), tPA (r = 0.40, P = 0.002), and leptin (r = 0.41, P = 0.002)... After adjustment for change in sc abdominal fat, the correlation between change in CRP, tPA, leptin, and adiponectin remained significantly associated with change in intraabdominal fat." (abstract, results)
pubmedfull study (doi) - context: Influences of the menopause transition and adverse childhood experiences on peripheral bas… (Brain, behavior, & immunity - health 2021) · cited 17x in the literature
"Log IL-6 levels were higher in the late perimenopause versus premenopause (p = 0.035). Menopause stage × ACE interaction was observed for log IL-6, IL-1β, and TNF-α (p = 0.042, p = 0.054, p = 0.053, respectively); for individuals with high (≥2) ACE exposure, IL-6 was higher in the late perimenopause (p = 0.015) while IL-1β and TNF-α were lower in the postmenopause versus premenopause (p = 0.019 and p = 0.020)." (abstract, results)
pubmedfull study (doi)
Lipopolysaccharide (LPS) can cross the blood-brain barrier and activate microglial immune cells, inducing brain inflammation.
"It can enter into almost any tissue, including crossing the blood-brain barrier. So, it does a good job of doing that. When it does cross the blood-brain barrier, it does induce inflammation in the brain. It activates something called microglial cells, which are the immune cells in the brain and central nervous system." (said at 0:11:40)
While lipopolysaccharide (LPS) activates microglial cells and induces neuroinflammation, the speaker's claim that LPS 'does a good job' of crossing the blood-brain barrier (BBB) is overstated. Quantitative pharmacokinetic studies in animal models (such as Banks et al., 2010) show that intact LPS penetrates the BBB only minimally (roughly 0.025% of an intravenous dose enters the CNS). Instead of freely penetrating the brain, circulating LPS primarily triggers neuroinflammation by acting on endothelial cells of the BBB, circumventricular organs, vagal afferents, or by disrupting BBB integrity and promoting peripheral cytokine signaling.
- contradicts: Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. (Brain, behavior, and immunity 2010) · cited 362x in the literature
"Brain endothelia also sequestered small amounts of I-LPS and about 0.025% of an intravenously injected dose of I-LPS crossed the BBB to enter the CNS... In conclusion, brain uptake of circulating I-LPS is so low that most effects of peripherally administered LPS are likely mediated through LPS receptors located outside the BBB." (abstract, results)
pubmedfull study (doi) - supports: LPS-Induced Neuroinflammation in Neurodegenerative Diseases: A Double-Edged Sword? (Molecular neurobiology 2026) · cited 1x in the literature
"Lipopolysaccharide (LPS), a glycolipid endotoxin derived from Gram-negative bacteria, activates Toll-like receptor 4 (TLR4) signaling in microglia and astrocytes, initiating neuroimmune cascades characterized by pro-inflammatory cytokine release, oxidative stress, and glial reactivity." (abstract, results, passage verified)
pubmedfull study (doi)
Lipopolysaccharide (LPS) interferes with serotonin and dopamine binding in the brain.
"LPS also interferes with serotonin and dopamine binding in the brain, which means that your happy hormone and your hormone that drives motivation and reward centers, that's not working very well." (said at 0:12:21)
The claim overstates preclinical animal findings. In rodent models, systemic administration of lipopolysaccharide (LPS) causes neuroinflammation that alters monoaminergic receptor binding in specific brain regions, but these changes are receptor- and region-specific (for instance, decreasing 5-HT1A binding in the hippocampus while increasing dopamine D2 receptor binding in the nucleus accumbens, with no effect on D1 or 5-HT2A receptors). Generalizing these complex, region-specific rodent changes to a blanket assertion that LPS straightforwardly disrupts serotonin and dopamine receptor binding and function in humans is unsupported by direct clinical evidence.
The American Diabetes Association published a paper stating that the primary insult starting insulin resistance is endotoxins (LPS).
"even they published almost now nine years ago that the primary insult, and this is this is quoted from a paper published by the American Diabetes Association, the primary insult that starts the process of insulin resistance is the presence of endotoxins, which is the LPS." (said at 0:16:20)
A landmark 2007 study published in the journal Diabetes (an official journal of the American Diabetes Association) by Cani et al. demonstrated that continuous subcutaneous infusion of bacterial lipopolysaccharide (LPS) in mice induced low-grade inflammation, weight gain, and hepatic insulin resistance, identifying LPS as a 'triggering factor' for diet-induced metabolic disorders. However, attributing this as an official statement of the American Diabetes Association, or framing preclinical rodent research as conclusive proof that endotoxins are the primary insult initiating insulin resistance in humans, overstates both the nature of the publication (an original animal research paper, not an ADA guideline or consensus statement) and the clinical evidence.
Approximately 40% of adults experience adult-onset acne.
"Somewhere around 40% of adults start to experience adult onset of acne, right?" (said at 0:17:50)
The claim conflates either the overall prevalence of adult acne in women or the subset of adult acne sufferers whose condition began in adulthood. Epidemiological surveys (such as Poli et al., 2001) found an overall acne prevalence of approximately 41% among adult women aged 25–40, and reported that 41% of those affected had late-onset acne (no history of adolescent acne). Consequently, adult-onset acne occurs in approximately 17% of adult women in survey data (and lower in the general adult population including men), rather than 40% of all adults.
Normal bowel transit time in a beet test is between 24 and 30 hours.
"And what you want to see is, you know, somewhere between like 24 to 30-ish hours, right? Um if you're way before that if you're like 12, 13, 14 hours, then your bowels are moving too fast. And if you're in the 40-plus hour range, your bowels are moving too slow." (said at 0:29:10)
While 24 to 30 hours is within the typical median range for whole-gut transit time in healthy adults, defining the normal reference range so narrowly—and classifying transit over 40 hours as abnormally slow—is overstated. In physiological and clinical studies using radiopaque markers, ingestible sensors, or dye tests, normal whole-gut transit time displays wide inter-individual variability, commonly ranging from 12 to 72 hours (with upper limits of normal often exceeding 70 to 120 hours depending on age, sex, diet, and defecation frequency).
A 2015 paper in Frontiers in Immunology concluded that endotoxemia is the primary cause of morbidity and mortality worldwide.
"and in fact a paper published in 2015 in Frontiers of Immunology concluded the same. They said that stress induced endotoxemia or endotoxemia on its own is the number one cause of morbidity and mortality worldwide." (said at 0:44:06)
The cited 2015 review in Frontiers in Immunology ('Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability') notes that chronic non-communicable diseases (NCDs) are the leading causes of disability and mortality worldwide. The authors present a narrative hypothesis that stress-induced intestinal permeability leading to endotoxin translocation may play a contributory or causal role in the low-grade inflammation associated with these diseases. The review does not conclude or establish that endotoxemia itself is the primary or number one cause of worldwide morbidity and mortality.
A published 30-day randomized controlled trial of a spore-based probiotic formula showed a 75% reduction in post-meal endotoxemia/LPS.
"and we published in 2017 the first time a paper has been published on a probiotic that alleviates that LPS endotoxemia. Right? So, we showed in a 30-day study, in a simple randomized controlled trial, 38 30-day study with people who had profound endotoxemia, meaning we were screening people for those that had a huge amount of LPS that leaks through. We were able to show a 75% reduction in that LPS in just that 30-day period." (said at 0:45:28)
A 2017 randomized controlled trial evaluated a 30-day supplementation of a 5-strain Bacillus spore-based probiotic in individuals identified as dietary endotoxemia 'responders' (at least a 5-fold post-meal increase in serum endotoxin). The study found a 42% reduction in postprandial endotoxin/LPS in the probiotic group (alongside a 36% increase in the placebo group), not a 75% direct reduction in LPS levels.
Microbiologist Raúl Cano isolated viable Bacillus endospores dating 25 to 40 million years old from ancient bees preserved in amber.
"His name is Raúl Cano. He did all of that work... him and his team did all the work where they found microbes in the guts of ancient fossilized honeybees that were fossilized in amber just like the mosquito in Jurassic Park, right? And he was able to isolate Bacillus endospores from them that were 50 million and as old as 250 million years old." (said at 0:50:54)
Raúl Cano and colleagues published the isolation and revival of viable Bacillus endospores (most closely related to Bacillus sphaericus) from the abdominal contents of extinct stingless bees preserved in 25- to 40-million-year-old Dominican amber (PMID: 7538699). However, the spoken claim exaggerates the age by asserting these bee-derived isolates were 'as old as 250 million years old.' Claims of viable 250-million-year-old bacteria come from separate studies of Permian salt crystals (halite), not amber-entombed bees. Furthermore, ancient DNA and spore revival claims from millions of years ago remain contentious in paleomicrobiology due to debates surrounding contamination and background radiation damage over geological timescales.
- supports: Revival and identification of bacterial spores in 25- to 40-million-year-old Dominican amb… (Science (New York, N.Y.) 1995) · cited 639x in the literature
"A bacterial spore was revived, cultured, and identified from the abdominal contents of extinct bees preserved for 25 to 40 million years in buried Dominican amber. Rigorous surface decontamination of the amber and aseptic procedures were used during the recovery of the bacterium. Several lines of evidence indicated that the isolated bacterium was of ancient origin and not an extant contaminant. The characteristic enzymatic, biochemical, and 16S ribosomal DNA profiles indicated that the ancient bacterium is most closely related to extant Bacillus sphaericus." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Bacillus DNA in fossil bees: an ancient symbiosis? (Applied and environmental microbiology 1994) · cited 95x in the literature
"We report here the isolation of DNA from abdominal tissue of four extinct stingless bees (Proplebeia dominicana) in Dominican amber, PCR amplification of a 546-bp fragment of the 16S rRNA gene from Bacillus spp., and their corresponding nucleotide sequences." (abstract, results, passage verified)
pubmedfull study (doi)
Bitter taste receptors located throughout the digestive tract account for nearly 50% of all digestive signaling in the body.
"turning on of the bitter taste receptors throughout the digestive tract accounts for almost 50% of all of the digestive signaling. Right? So, think of them as switches going through this massive machine. Turning on these switches to effectuate the digestive process requires bitter taste receptors being activated by bitter compounds" (said at 0:57:18)
While bitter taste receptors (TAS2Rs / T2Rs) are expressed throughout the gastrointestinal mucosa and play documented roles in chemoreception, hormone secretion (such as GLP-1), gastric acid secretion, motility, and metabolic regulation, there is no scientific basis or quantification showing that they account for "nearly 50% of all digestive signaling." Gastrointestinal digestion and motility are coordinated by a complex, multi-layered system dominated by the enteric nervous system (ENS), autonomic nervous system input (vagus and sympathetic nerves), peptide hormones (gastrin, CCK, secretin, motilin, ghrelin, etc.), mechanical stretch receptors, and multiple non-bitter nutrient receptors (such as sweet/umami TAS1Rs, free fatty acid GPCRs, and amino acid transporters). Claiming a specific, precise figure of 50% for bitter taste receptors dramatically overstates their contribution relative to these primary neural and hormonal signaling networks.
- context: Bitter taste receptors as sensors of gut luminal contents. (Nature reviews. Gastroenterology & hepatology 2025) · cited 42x in the literature
"These bitter taste receptors are expressed in functionally distinct types of gastrointestinal mucosal cells, including enteroendocrine cells, which, upon stimulation, increase intracellular Ca 2+ and release signalling molecules that regulate gut chemosensory processes critical for digestion and absorption of nutrients, for neutralization and expulsion of harmful substances, and for metabolic regulation." (abstract, passage verified)
pubmedfull study (doi) - context: Intestinal bitter taste receptors in health: a multifactorially regulated role from the pe… (Critical reviews in food science and nutrition 2026) · cited 1x in the literature
"Intestinal bitter taste receptors (TAS2Rs) play a crucial role in detecting bitter compounds and regulating the release of intestinal hormones, such as glucagon-like peptide-1 (GLP-1), and gastric emptying, which influence appetite, satiety, food intake, and energy balance." (abstract, passage verified)
pubmedfull study (doi)
In a 30-day trial of a spore-based probiotic formula, participants consuming a 2,000-calorie meal experienced a 60% to 70% drop in postprandial ghrelin levels along with a significant increase in leptin.
"what we saw then, after just 30 days of not adjusting diet, lifestyle, or anything else, just taking the this the spore-based probiotic formula, what we saw was a after we gave them the 2,000 calorie meal, we saw about a 60, 70% drop in the ghrelin, the hunger hormone, and a significant increase in leptin." (said at 0:47:44)
A 30-day randomized pilot trial (McFarlin et al., 2017) evaluated a 5-strain Bacillus spore-based probiotic following a high-calorie/high-fat meal challenge in individuals with postprandial dietary endotoxemia. While the trial did find lower postprandial ghrelin concentrations in the probiotic group compared to placebo (6.8 ± 0.4 vs. 8.3 ± 1.1, P = 0.017), this represents an approximately 18% difference between groups, substantially less than the 60% to 70% reduction claimed.
Bitter receptors control upwards of half of all digestive signals in the human body.
"what a bitter is, you know, and it controls upwards of half of all your digestive signals, which is amazing." (said at 1:04:45)
Extraoral bitter taste receptors (TAS2Rs) are expressed throughout the human gastrointestinal tract on enteroendocrine, Paneth, goblet, and tuft cells, where their activation influences gut motility, mucosal defence, and the secretion of digestive and satiety hormones like GLP-1 and CCK. However, there is no scientific basis for the claim that they control 'upwards of half' of all digestive signals. Gastrointestinal physiology relies on an extensive network of diverse inputs, including the enteric and autonomic nervous systems, mechanoreceptors, and numerous specialized chemosensory receptors for macronutrients (carbohydrates, amino acids, and fats via TAS1Rs, calcium-sensing receptors, and free fatty acid receptors), along with dozens of peptide hormones and neurotransmitters.
- context: Bitter taste receptors as sensors of gut luminal contents. (Nature reviews. Gastroenterology & hepatology 2025) · cited 42x in the literature
"These bitter taste receptors are expressed in functionally distinct types of gastrointestinal mucosal cells, including enteroendocrine cells, which, upon stimulation, increase intracellular Ca 2+ and release signalling molecules that regulate gut chemosensory processes critical for digestion and absorption of nutrients, for neutralization and expulsion of harmful substances, and for metabolic regulation." (abstract, results, passage verified)
pubmedfull study (doi) - context: Intestinal bitter taste receptors in health: a multifactorially regulated role from the pe… (Critical reviews in food science and nutrition 2026) · cited 1x in the literature
"Intestinal bitter taste receptors (TAS2Rs) play a crucial role in detecting bitter compounds and regulating the release of intestinal hormones, such as glucagon-like peptide-1 (GLP-1), and gastric emptying, which influence appetite, satiety, food intake, and energy balance." (abstract, results, passage verified)
pubmedfull study (doi)
1 Needs context
Screening of healthy, normal-BMI adults in their mid-20s showed that approximately 55% had elevated LPS levels indicative of profound leaky gut.
"when we did our leaky gut studies, we were doing it in people in their mid-20s who were by FDA standards healthy normals, right? So, they didn't have any conditions, they didn't have any issues, weren't on any drugs or management of any disease, and they were all a normal BMI and so on. But, about 55% of them had very profound leaky gut. Right? Very elevated levels of LPS." (said at 1:01:12)
The claim refers to a screening study conducted in healthy, normal-BMI young adults evaluating postprandial dietary endotoxemia (elevated lipopolysaccharide [LPS] levels, often framed as indicative of intestinal permeability or 'leaky gut'). In a trial by Campbell et al. (2017), healthy subjects were screened for postprandial dietary endotoxemia following a high-fat challenge meal, categorizing participants as 'responders' if their postprandial serum endotoxin increased significantly (at least 5-fold) over baseline. While elevated postprandial LPS levels were indeed found in a substantial subset of seemingly healthy, normal-weight individuals, framing transient postprandial endotoxemia after a high-fat meal challenge as 'profound leaky gut' requires context, as postprandial endotoxemia is a temporary physiological response to lipid absorption rather than definitive proof of chronic intestinal barrier breakdown.
17 Supported by research
Approximately 40% to 50% of the microbes in the human gut are made up of gram-negative bacteria.
"and a lot of people have around 40-50% of the microbes in their gut made up of gram-negative bacteria." (said at 0:03:09)
The human intestinal microbiota is predominantly composed of two major bacterial phyla: Firmicutes (primarily Gram-positive) and Bacteroidetes (Gram-negative), alongside other groups such as Proteobacteria. Depending on individual variation, enterotype, and the analytical technique used (e.g., electron microscopy, classical Gram staining, or 16S rRNA sequencing), Gram-negative bacteria frequently constitute between 30% and 50% (or more) of the microbial community in many individuals.
- supports: Molecular studies neglect apparently gram-negative populations in the human gut microbiota… (Journal of clinical microbiology 2013) · cited 54x in the literature
"The Mann-Whitney test revealed that Gram-negative proportions of the prokaryotes obtained by Gram staining, TEM, and pyrosequencing differed according to the analysis used, with Gram-negative prokaryotes yielding median percentages of 70.6%, 31.0%, and 16.4%, respectively." (abstract, results, passage verified)
pubmedfull study (doi) - context: Short-term effect of antibiotics on human gut microbiota. (PloS one 2014) · cited 351x in the literature
"At the species level, our findings unexpectedly revealed that both antibiotic types increased the proportion of several unknown taxa belonging to the Bacteroides genus, a Gram-negative group of bacteria" (abstract, results, passage verified)
pubmedfull study (doi)
Estrogen increases glycogen production in the vaginal canal, which feeds Lactobacilli that produce lactic acid to maintain vaginal pH.
"estrogen acts as a metabolite for microbes in the lining of the vaginal canal that increases something called glycogen production. And that glycogen production feeds the lactobacilli that are in the vaginal canal, which then create lactic acid and maintain a healthy vaginal canal." (said at 0:07:45)
Published gynecologic and microbiological literature well establishes that estrogen stimulates the proliferation and maturation of vaginal epithelial cells and the accumulation of glycogen in the vaginal epithelium. This glycogen serves as a primary substrate that is metabolized by vaginal Lactobacillus species to produce lactic acid, which acidifies the vaginal microenvironment (typically maintaining a pH between 3.8 and 4.5) and protects against pathogenic infections.
Standard starting doses of GLP-1 medications are 0.25 mg for semaglutide and 2.5 mg for tirzepatide.
"They're being given 0.25 of semaglutide or 2.5 of tirzepatide. That is the standard starting dose. That is the same dose we give folks who are diabetic, folks who are dealing with obesity" (said at 0:25:15)
Standard clinical titration protocols and trial designs for subcutaneous semaglutide and tirzepatide initiate treatment at 0.25 mg once weekly and 2.5 mg once weekly, respectively. These initial starting doses are designed to reduce gastrointestinal adverse effects before dose escalation.
The use of GLP-1 receptor agonists is correlated with higher rates of small intestinal bacterial overgrowth (SIBO).
"there is a correlation to higher rates of SIBO, small intestinal bacterial overgrowth, when people are using GLP-1s." (said at 0:18:46)
A large retrospective multicenter cohort study analyzing global electronic health records (TriNetX) examined 216,173 propensity-score-matched pairs of adult patients with type 2 diabetes. Patients initiating GLP-1 receptor agonists or dual GLP-1/GIP receptor agonists had a significantly higher rate of incident, diagnostically confirmed small intestinal bacterial overgrowth (SIBO) within the first year compared to those taking other second-line diabetes medications (0.177 vs. 0.083 per 1,000 patient-years; HR 2.14, 95% CI 1.13–4.07). The certainty is rated low due to the observational nature of the cohort data.
Data on standard-dose liraglutide shows that GLP-1 receptor agonist use decreases endogenous GLP-1 production in L cells for a substantial period.
"The other thing to note is there is some data showing that GLP-1 use at standard dose, and this was in liraglutide, decreased endogenous production of GLP-1 in the L cells for a substantial amount of time." (said at 0:32:27)
A randomized controlled trial evaluating standard-dose liraglutide (1.8 mg daily) over 14 weeks in adults with overweight/obesity and prediabetes found that liraglutide significantly reduced postprandial endogenous GLP-1 concentrations during an 8-hour mixed-meal tolerance test (endogenous GLP-1 AUC 13.1 vs. 24.2 pmol/L × 8 h at baseline, P ≤ 0.005). The authors concluded that GLP-1 receptor agonists appear to directly suppress the endogenous production of proglucagon-derived peptides in intestinal L cells independently of weight loss.
Approximately 80% of vagus nerve fibers are afferent (transmitting signals from gut to brain), while only 20% are efferent (transmitting from brain to gut).
"if you look at the nerve um you know, structure of of that of the vagus nerve itself, it's 80% of the nerves are what we call afferent nerves, which means 80% of the information is actually going from the gut to the brain. And only 20% coming from the brain down to the gut" (said at 0:34:40)
Extensive anatomical and physiological literature confirms that the vagus nerve is a mixed nerve predominantly composed of sensory (afferent) fibers. Approximately 80% of vagal nerve fibers transmit sensory signals from visceral organs (including the gastrointestinal tract) to the central nervous system, while approximately 20% are motor/secretory (efferent) fibers transmitting signals from the brain to visceral targets.
Sustained high blood sugars cause vagus nerve damage in individuals with diabetes.
"The the high blood sugars for sustained extended periods of time does damage on the vagus nerve and that connection is in many cases already compromised" (said at 0:36:03)
Diabetic autonomic neuropathy is a well-established complication of chronic diabetes, where prolonged hyperglycemia causes structural and functional damage to autonomic nerves. The vagus nerve, which provides primary parasympathetic innervation to the cardiovascular and gastrointestinal systems, is recognized as a major and early target of diabetes-induced nerve injury, leading to reduced cardiac vagal tone, altered heart rate variability, and gastrointestinal dysmotility.
- supports: Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin c… (Experimental neurology 2001) · cited 57x in the literature
"These data suggest that an increase in vagus nerve NGF is an early, but transient, response to the diabetic hyperglycemia and that a subsequent reduction in neuronal access to NGF and NT-3 secondary to decreased retrograde axonal transport may play a role in diabetes-induced damage to the vagus nerve." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variabi… (Diabetes 1990) · cited 28x in the literature
"These data suggest that autonomic neuropathy involving the vagus nerve is metabolically induced by demonstrating that inhibition of the polyol pathway significantly delays the occurrence of functional and structural autonomic neuropathy despite the presence of hyperglycemia." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Ultrasonographic measurement of cross-sectional area of the vagus nerve in patients with d… (Annals of medicine and surgery (2012) 2026)
"Diabetic neuropathy, a prevalent complication of diabetes mellitus (DM), often involves autonomic dysfunction, with the vagus nerve (VN) being an early target." (abstract, background, passage verified)
pubmedfull study (doi)
Gut microbes metabolize cortisol into byproducts that alter renal potassium-sodium ratios, increasing fluid retention and raising blood pressure.
"there are microbes in the gut that can actually metabolize cortisol, and the metabolic byproducts of that go to the kidneys, and they shift the the solute and solvent ratios in the kidneys. So, the potassium-sodium ratios, which then increases the amount of water that is going back into circulation. So, then the kidneys actually press more water back into circulation in order to increase blood pressure." (said at 0:39:01)
The speaker accurately describes a recognized pathophysiological mechanism known as the glycyrrhetinic acid-like factor (GALF) pathway. Published biochemical and preclinical evidence demonstrates that certain gut microbiota metabolize endogenous glucocorticoids such as cortisol into steroid byproducts. These microbial metabolites enter the circulation and can act as inhibitors of renal 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). When 11β-HSD2 is inhibited, unmetabolized cortisol binds to and activates renal mineralocorticoid receptors, altering renal electrolyte handling (promoting sodium retention and potassium excretion), which increases water reabsorption into the circulation and elevates blood pressure. Because this mechanism is established primarily through in vitro assays, animal models, and mechanistic reviews, the overall certainty of evidence in clinical populations is very low.
- supports: Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era. (Steroids 2017) · cited 66x in the literature
"A body of literature demonstrates that bacterial products of glucocorticoid metabolism are absorbed into the portal circulation, and pass through the kidney before excretion into urine... 11β-HSD2 acts as a "guardian" enzyme protecting the mineralocorticoid receptor from excess cortisol, preventing sodium and water retention in the normotensive state... Bacterially derived glucocorticoid metabolites may cause hypertension in some patients by a similar mechanism." (abstract)
pubmedfull study (doi) - supports: Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing an… (Physiological genomics 2019) · cited 32x in the literature
"In this review, we primarily focus on the potential role selected gut bacteria play in metabolizing the endogenous glucocorticoids corticosterone and cortisol. Those generated steroid metabolites, when reabsorbed in the intestine back into the circulation, produce biological effects most notably as inhibitors of 11β-hydroxysteroid dehydrogenase (11β-HSD) types 1 and 2. Inhibition of the dehydrogenase actions of 11β-HSD, particularly in kidney and vascular tissue, allows both corticosterone and cortisol the ability to bind to and activate mineralocorticoid receptors with attended changes in sodium handling and vascular resistance leading to increases in blood pressure." (abstract, passage verified)
pubmedfull study (doi)
Interleukin-6 (IL-6) can directly re-trigger the hypothalamic-pituitary-adrenal (HPA) axis without the presence of an external stressor.
"LPS also increases IL-6, which we mentioned before. But one of the things we didn't mention is that IL-6 can actually re-trigger the HPA axis. Even though you don't have another stimulus" (said at 0:40:20)
Interleukin-6 (IL-6) is an established activator of the hypothalamic-pituitary-adrenal (HPA) axis. Controlled clinical trials administering recombinant human IL-6 to healthy human volunteers have demonstrated that IL-6 alone triggers marked, dose-dependent increases in adrenocorticotropic hormone (ACTH) and cortisol secretion without requiring an external psychological or physical stressor.
- supports: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. (American journal of physiology. Endocrinology and metabolism 2003) · cited 1131x in the literature
"rhIL-6 induced increased levels of plasma cortisol and, consequently, an increase in circulating neutrophils and a decrease in the lymphocyte number without effects on plasma epinephrine, body temperature, mean arterial pressure, or heart rate." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy … (Neuroendocrinology 1997) · cited 226x in the literature
"Plasma adrenocorticotropic-hormone concentrations increased dramatically and dose-dependently in all the patients who received the 3.0- and 10.0-microgram/kg doses of IL-6, respectively, peaking to 150 and 255 pg/ml at 60 min, and slowly returning to normal by 4 h. Corresponding plasma cortisol levels peaked dose-dependently between 90 and 150 min, but remained elevated throughout the sampling period." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep fu… (The Journal of clinical endocrinology and metabolism 1998) · cited 160x in the literature
"The cytokine induced a prolonged increased in plasma concentrations of ACTH and cortisol (P < 0.001), but led to a decrease in TSH concentrations (P < 0.01)." (abstract, results)
pubmedfull study (doi)
Certain pathogenic bacteria express virulence factors and increase toxin production in response to host stress hormones like epinephrine, norepinephrine, and cortisol.
"some pathogens have learned that when the host is under stress and they're actually measuring your stress hormones like your epinephrine, norepinephrine, cortisol, and so on. When those stress hormones are elevated, that's when they they express their virulence factors and their toxin production" (said at 0:41:55)
The claim is supported by scientific research in the field of microbial endocrinology. Pathogenic bacteria (such as enterohemorrhagic Escherichia coli and Vibrio cholerae) possess sensor proteins (such as the sensor histidine kinase QseC) that recognize mammalian stress hormones, including epinephrine and norepinephrine. Exposure to these host catecholamine stress hormones directly triggers signaling cascades that increase bacterial growth, motility, expression of virulence factors, and toxin production (such as Shiga toxins stx1 and stx2 in E. coli).
- supports: Escherichia coli O157:H7 gene expression in the presence of catecholamine norepinephrine. (FEMS microbiology letters 2007) · cited 63x in the literature
"After 5 h of exposure to norepinephrine, treatment and control cultures... were harvested... There was a dramatic increase in the expression of virulence factor transcripts including stx1, stx2, and eae." (abstract, results)
pubmedfull study (doi) - supports: The QseC adrenergic signaling cascade in Enterohemorrhagic E. coli (EHEC). (PLoS pathogens 2009) · cited 246x in the literature
"The hormones epinephrine and norepinephrine play a central role in stress responses in mammals... Through QseC, EHEC activates expression of metabolic, virulence and stress response genes, synchronizing the cell response to these stress hormones." (abstract)
pubmedfull study (doi) - supports: Influences of stress hormones on microbial infections. (Microbial pathogenesis 2019) · cited 68x in the literature
"The most studied neuroendocrine hormonal family from a microbial endocrinology perspective is the catecholamine comprising of norepinephrine, epinephrine, and dopamine. It is of importance that catecholamine affects the growth and virulence of bacteria... exposure of genes to stress hormones enhances the expression of genes involved in bacterial virulence." (abstract, passage verified)
pubmedfull study (doi)
Normal physiological human gastric pH ranges from 1.2 to 1.3, which is the third or fourth lowest stomach pH among animal species.
"The pH is very low in in normal physiological pH, it could be 1.2, 1.3. That's a very, very acidic environment. In fact, humans have I think the third or the fourth lowest pH in the animal kingdom, only next to like vultures" (said at 0:49:06)
A systematic review compiling vertebrate gastric acidity data found that normal human baseline gastric pH is exceptionally acidic (typically measured around 1.2 to 1.5). In comparative analyses across mammal and bird taxa, human stomach acidity ranks among the most acidic vertebrates, clustering with obligate and facultative scavengers (such as vultures) rather than generalist primates or herbivores.
Activation of bitter taste receptors stimulates L cells to secrete GLP-1, CCK, GIP, and PYY, and activates AMPK.
"Aren't bitter taste receptors what signal the L cells of the gut to kick up, too? And that's what The L cells are what secrete GLP-1. GUEST1: That's exactly right, yeah... It kicks up, you know, CCK, GLP-1s, GIPs. It kicks up the PYY, yep. And AMPK as well" (said at 0:58:37)
Activation of bitter taste receptors (TAS2Rs/T2Rs) expressed on enteroendocrine cells in the gut stimulates the secretion of satiety and incretin hormones, including GLP-1, PYY, and CCK, and triggers downstream activation of AMP-activated protein kinase (AMPK) signaling. While classical histology attributes CCK primarily to I cells and GIP to K cells (whereas GLP-1 and PYY are secreted by L cells), colonic and intestinal enteroendocrine cells expressing bitter taste receptors colocalize with and secrete these peptides upon bitter agonist stimulation.
- supports: Expression of the Bitter Taste Receptor, T2R38, in Enteroendocrine Cells of the Colonic Mu… (PloS one 2016) · cited 71x in the literature
"In both OW/OB and NW individuals, all T2R38-IR cells contained CgA-IR supporting they are enteroendocrine. In both groups, T2R38-IR colocalized with CCK-, GLP1- or PYY-IR." (abstract, passage verified)
pubmedfull study (doi) - supports: Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated… (Frontiers in pharmacology 2018) · cited 70x in the literature
"CuB ameliorated hyperglycemia by activating intestinal AMPK levels and by inducing plasma GLP-1 and insulin release in diabetic mice. This hypoglycemic action was decreased in dorsomorphin-injected mice and α-gustducin null mice. Moreover, systemic inhibition study in differentiated NCI-H716 cell line showed that CuB-mediated GLP-1 secretion was involved in activation of AMPK through α-gustducin and Gβγ-signaling of taste receptors." (abstract, passage verified)
pubmedfull study (doi) - supports: The gut odorant receptor and taste receptor make sense of dietary components: A focus on g… (Critical reviews in food science and nutrition 2024) · cited 24x in the literature
"Recent studies indicate that gut cells sense dietary components including fatty acid, carbohydrate, and phytochemical by activating relevant ORs, thereby modulating GLP-1, PYY, CCK, and 5-HT secretion. Similarly, gut sweet, umami, and bitter receptors can regulate the gut hormone secretion and maintain homeostasis in response to dietary components." (abstract, passage verified)
pubmedfull study (doi)
Circulating bile activates the nuclear farnesoid X receptor (FXR) in the distal small intestine, prompting intestinal cells to secrete antimicrobial peptides that inhibit bacterial overgrowth.
"The other thing that bile does every time it circulates through the digestive tract when food is present is that it upregulates something called a nuclear FXR receptor. That nuclear FXR receptor, which is in the distal part of the small bowel, tells your intestinal cells in the small bowel to produce antimicrobial compounds when food is present to suppress the growth of bacteria in the small intestine" (said at 0:59:28)
The speaker accurately describes the physiological mechanism linking bile acid circulation, the farnesoid X receptor (FXR), and antimicrobial defense in the small bowel. Bile acids circulating through the intestine act as endogenous ligands for the nuclear receptor FXR, which is predominantly expressed in the distal small intestine (ileum). FXR activation induces transcriptional programs that include the expression of antimicrobial compounds and preservation of the mucosal barrier, suppressing bacterial overgrowth and preventing bacterial translocation across the gut-liver axis.
Excessive accumulation of secondary bile salts, produced when gut microbes convert primary bile, can cause inflammation in the large intestine.
"there are microbes in your gut that'll convert that bile into what we call secondary bile salts. And those secondary bile salts can be very useful and helpful, but if you do too much of it, it can actually create inflammation in the large bowel." (said at 1:01:08)
The speaker's statement accurately reflects the physiology and pathophysiology of bile acid metabolism. Primary bile acids synthesized by the liver are metabolized by colonic bacteria into secondary bile acids (such as deoxycholic acid and lithocholic acid). While physiological concentrations contribute to homeostatic signaling, excessive levels or detergent activity can disrupt mucosal integrity, promote bacterial translocation, and trigger colonic epithelial inflammation.
- supports: Bile acid detergency: permeability, inflammation, and effects of sulfation. (American journal of physiology. Gastrointestinal and liver physiology 2022) · cited 56x in the literature
"di-α-hydroxy bile acids are the only bile acids with detergent effects that include mucin depletion, mucosal damage, bacterial uptake, and microscopic inflammation that may be manifest in diseases associated with no overt inflammation of the mucosa, such as bile acid diarrhea, ileal diseases such as neuroendocrine tumors, ileal resection, and nonalcoholic steatohepatitis." (abstract, background)
pubmedfull study (doi) - supports: Gut bacteria Prevotellaceae related lithocholic acid metabolism promotes colonic inflammat… (Journal of translational medicine 2025) · cited 35x in the literature
"The conversion of primary bile acids to secondary bile acids by the gut microbiota has been implicated in colonic inflammation. This study investigated the role of gut microbiota related bile acid metabolism in colonic inflammation in both patients with inflammatory bowel disease (IBD) and a murine model of dextran sulfate sodium (DSS)-induced colitis." (abstract, results, passage verified)
pubmedfull study (doi)
One of the primary biological functions of bitter taste perception in the mouth is to detect potential dietary poisons.
"one of the most important aspects of the bitters for the mouth is to detect potential poisons." (said at 1:05:35)
The scientific consensus in evolutionary biology and gustatory physiology establishes that bitter taste perception evolved primarily as a protective mechanism to detect and deter the ingestion of naturally occurring toxic substances, such as plant alkaloids and poisons.
The cephalic phase response increases salivation and gastric secretions to prepare the digestive system for incoming food.
"The cephalic response is just your brain getting ready for food, right? So, it starts increasing salivation. It starts increasing some gastric secretions. Gets your body ready for food coming in" (said at 1:05:50)
The cephalic phase response is an established physiological reflex mediated by the central and autonomic nervous systems (primarily via the vagus nerve) triggered by sensory cues such as the sight, smell, or taste of food. It stimulates salivation, gastric acid and enzyme secretion, and pancreatic secretions in anticipation of nutrient ingestion to prepare the gastrointestinal tract for digestion.
Smelling and seeing food triggers the cephalic phase response.
"you can actually increase the cephalic response just by smelling food and seeing food. And we all have done that, right? You smell bacon, for example, and you're like, "Ah." Your mouth starts watering, right? That's a cephalic response." (said at 1:06:15)
The claim is supported by established human physiological research. Cephalic phase responses—including anticipatory salivation, digestive enzyme secretion, and hormonal shifts—are rapid preabsorptive physiological reactions triggered by sensory cues such as the sight, smell, taste, and texture of food.
- supports: A stepwise approach investigating salivary responses upon multisensory food cues. (Physiology & behavior 2020) · cited 25x in the literature
"Exposure to sensory food cues such as smell, vision, taste and/or texture may trigger anticipatory physiological responses such as salivation, participating on adequate metabolism of the signaled food." (abstract, passage verified)
pubmedfull study (doi) - supports: Physiologic responses to sensory stimulation by food: nutritional implications. (Journal of the American Dietetic Association 1997) · cited 190x in the literature
"Mere exposure to the sight, smell, taste, and textural attributes of foods elicits myriad digestive, endocrinologic, thermogenic. cardiovascular, and renal responses. The responses are rapid (generally occurring within minutes of sensory stimulation), small (relative to the magnitude achieved when food is actually being metabolized), and transient (returning to near-baseline levels within minutes). ... They are termed preabsorptive or cephalic phase responses." (abstract, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.